| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance.
|
Mol Carcinog
|
2011
|
2.53
|
|
2
|
Special problems encountering surgical management of large retroperitoneal schwannomas.
|
World J Surg Oncol
|
2008
|
1.46
|
|
3
|
Expression of microRNAs in patients with pancreatic cancer and its prognostic significance.
|
Pancreas
|
2013
|
1.26
|
|
4
|
Successful treatment with the mTOR inhibitor everolimus in a patient with perivascular epithelioid cell tumor.
|
World J Surg Oncol
|
2012
|
1.03
|
|
5
|
A review on the role of microRNA in biology, diagnosis, and treatment of pancreatic adenocarcinoma.
|
Pancreas
|
2012
|
1.01
|
|
6
|
Ischemic preconditioning versus intermittent vascular occlusion in liver resections performed under selective vascular exclusion: a prospective randomized study.
|
Am J Surg
|
2006
|
0.95
|
|
7
|
Pancreatic leakage after pancreaticoduodenectomy: the impact of the isolated jejunal loop length and anastomotic technique of the pancreatic stump.
|
Pancreas
|
2009
|
0.91
|
|
8
|
Surgical approaches of resectable synchronous colorectal liver metastases: timing considerations.
|
World J Gastroenterol
|
2007
|
0.89
|
|
9
|
Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on letrozole or anastrozole. A phase II trial conducted by the Hellenic Group of Oncology (HELGO).
|
Tumori
|
2006
|
0.86
|
|
10
|
Clinicopathologic features of two rare cases of mesenchymal metastatic tumors in the pancreas: review of the literature.
|
Pancreas
|
2006
|
0.83
|
|
11
|
Concurrent insulinoma and pancreatic adenocarcinoma: report of a rare case and review of the literature.
|
World J Surg Oncol
|
2011
|
0.83
|
|
12
|
Association between biliary complications and technique of hilar division (extrahepatic vs. intrahepatic) in major liver resections.
|
World J Surg Oncol
|
2006
|
0.80
|
|
13
|
Transhepatic lactate gradient in relation to liver ischemia/reperfusion injury during major hepatectomies.
|
Liver Transpl
|
2006
|
0.80
|
|
14
|
The impact of ischemic preconditioning on hemodynamic, biochemical and inflammatory alterations induced by intra-abdominal hypertension: an experimental study in a porcine model.
|
Langenbecks Arch Surg
|
2012
|
0.80
|
|
15
|
Cystoid gossypiboma of the liver 15 years after cholecystectomy.
|
Am Surg
|
2011
|
0.79
|
|
16
|
Ovarian vein thrombosis mimicking acute abdomen: a case report and literature review.
|
World J Emerg Surg
|
2011
|
0.79
|
|
17
|
Association of FokI and PvuII polymorphisms with breast cancer staging and survival among Caucasian women: a prospective study.
|
J BUON
|
2014
|
0.78
|
|
18
|
Adjuvant systemic therapy protocol for Dukes' B2 and C resectable colon carcinoma.
|
Tumori
|
2002
|
0.77
|
|
19
|
Ischemia as a possible effect of increased intra-abdominal pressure on central nervous system cytokines, lactate and perfusion pressures.
|
Crit Care
|
2010
|
0.76
|
|
20
|
Managing injuries of hepatic duct confluence variants after major hepatobiliary surgery: an algorithmic approach.
|
World J Gastroenterol
|
2008
|
0.76
|
|
21
|
Gemcitabine combined with 5-fluorouracil for the treatment of advanced carcinoma of the pancreas.
|
In Vivo
|
2006
|
0.76
|
|
22
|
Multifocal retroperitoneal sarcoma.
|
Case Rep Surg
|
2013
|
0.75
|
|
23
|
Successful Treatment of a Severe Case of Fournier's Gangrene Complicating a Perianal Abscess.
|
Case Rep Med
|
2011
|
0.75
|
|
24
|
A Rare Coexistence of Retroperitoneal Pararenal Castleman's Disease with Focal Nodular Hyperplasia.
|
Case Rep Surg
|
2013
|
0.75
|
|
25
|
Paul of Aegina: landmark in surgical progress.
|
World J Surg
|
2003
|
0.75
|
|
26
|
The effect of hepatectomy on plasma lipolytic enzyme activity and circulating lipid levels: an experimental study on Wistar rat.
|
Hepatogastroenterology
|
2012
|
0.75
|
|
27
|
Bilateral obturator pyomyositis with visceral involvement in an immunocompetent adult patient treated without surgery.
|
Surg Infect (Larchmt)
|
2014
|
0.75
|